EN
At Washa Pharmaceuticals, quality is not just a requirement—it is the foundation of our operations. Our Quality Management System (QMS) integrates quality policies, operational processes, responsibilities, and resources into a cohesive framework that ensures product quality and regulatory compliance.
Our QMS is aligned with core objectives designed to ensure the safety, efficacy, and reliability of every product we distribute.
Strict adherence to Good Distribution Practices and Good Storage Practices to protect product quality.
Real-time tracking from procurement to delivery via our Warehouse Management System.
Proactive identification, assessment, and mitigation of risks to pharmaceutical quality and patient safety.
Regular internal audits, management reviews, and staff training programs to stay ahead of industry best practices.
Our QA and QC procedures ensure that all pharmaceutical products, from receipt through storage, handling, and distribution, meet the highest standards of safety, efficacy, and regulatory compliance.
All incoming shipments are cross-checked against purchase orders, bill of lading, certificate of analysis, and manufacturers' certificates. Products are inspected for physical damage, correct labeling, packaging, and conformance. Special attention is given to products requiring temperature control during transportation.
Products are stored under specified temperature, humidity, and lighting conditions monitored continuously. We apply First Expiry, First Out (FEFO) for stock rotation. Our Warehouse Management System (WMS) tracks batch numbers, expiration dates, and quantities in real-time, with periodic physical and digital stock audits.
All transportation methods are vetted to ensure products are handled under appropriate conditions. The entire distribution process is tracked to ensure products can be traced from the warehouse to the customer. We maintain strict procedures for handling returned goods and product recalls to avoid cross-contamination.
To prevent the entry of substandard, counterfeit, or falsified products into the supply chain, all incoming products are inspected for discrepancies. Suspicious products are immediately segregated into quarantine areas, and relevant regulatory bodies, such as EFDA, are notified immediately.
Our quality assurance team is available to provide documentation and answer any inquiries regarding our compliance and safety protocols.
Contact Quality Assurance